Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.

Peacock JE, Herrington DA, Wade JC, Lazarus HM, Reed MD, Sinclair JW, Haverstock DC, Kowalsky SF, Hurd DD, Cushing DA, Harman CP, Donowitz GR.

Ann Intern Med. 2002 Jul 16;137(2):77-87.

PMID:
12118962
2.

Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge.

Church LW, Le TP, Bryan JP, Gordon DM, Edelman R, Fries L, Davis JR, Herrington DA, Clyde DF, Shmuklarsky MJ, Schneider I, McGovern TW, Chulay JD, Ballou WR, Hoffman SL.

J Infect Dis. 1997 Apr;175(4):915-20.

PMID:
9086149
3.

An international traveler with fever, abdominal pain, eosinophilia, and a liver lesion.

Stark ME, Herrington DA, Hillyer GV, McGill DB.

Gastroenterology. 1993 Dec;105(6):1900-8. No abstract available.

PMID:
8253366
4.

Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites.

Edelman R, Hoffman SL, Davis JR, Beier M, Sztein MB, Losonsky G, Herrington DA, Eddy HA, Hollingdale MR, Gordon DM, et al.

J Infect Dis. 1993 Oct;168(4):1066-70.

PMID:
8376823
5.

Effects of ingested human anti-sporozoite sera on Plasmodium falciparum sporogony in Anopheles stephensi.

Davis JR, Beier MS, Beier JC, Pumpuni CB, Edelman R, Herrington DA, Clyde DF.

Am J Trop Med Hyg. 1993 Aug;49(2):174-80.

PMID:
8357079
6.
7.

Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Kotloff KL, Herrington DA, Hale TL, Newland JW, Van De Verg L, Cogan JP, Snoy PJ, Sadoff JC, Formal SB, Levine MM.

Infect Immun. 1992 Jun;60(6):2218-24.

8.

Urinary neopterin in volunteers experimentally infected with Plasmodium falciparum.

Brown AE, Herrington DA, Webster HK, Clyde DF, Sztein MB, Davis JR, Beier MS, Edelman R.

Trans R Soc Trop Med Hyg. 1992 Mar-Apr;86(2):134-6.

PMID:
1440769
9.

Plasmodium falciparum: in vitro characterization and human infectivity of a cloned line.

Davis JR, Cortese JF, Herrington DA, Murphy JR, Clyde DF, Thomas AW, Baqar S, Cochran MA, Thanassi J, Levine MM.

Exp Parasitol. 1992 Mar;74(2):159-68.

PMID:
1346766
10.

Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.

Herrington DA, Losonsky GA, Smith G, Volvovitz F, Cochran M, Jackson K, Hoffman SL, Gordon DM, Levine MM, Edelman R.

Vaccine. 1992;10(12):841-6.

PMID:
1455910
11.

Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax.

Herrington DA, Nardin EH, Losonsky G, Bathurst IC, Barr PJ, Hollingdale MR, Edelman R, Levine MM.

Am J Trop Med Hyg. 1991 Dec;45(6):695-701.

PMID:
1763796
12.
13.

Antigenic variation of Giardia lamblia in experimental human infections.

Nash TE, Herrington DA, Levine MM, Conrad JT, Merritt JW Jr.

J Immunol. 1990 Jun 1;144(11):4362-9.

PMID:
2341723
15.

Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD103.

Ketley JM, Kaper JB, Herrington DA, Losonsky G, Levine MM.

Infect Immun. 1990 May;58(5):1481-4.

16.

Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes.

Hollingdale MR, Appiah A, Leland P, do Rosario VE, Mazier D, Pied S, Herrington DA, Chulay JD, Ballou WR, Derks T, et al.

Trans R Soc Trop Med Hyg. 1990 May-Jun;84(3):325-9.

PMID:
2175464
17.

Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy.

Murphy JR, Clyde DF, Herrington DA, Baqar S, Davis JR, Palmer K, Cortese J.

Antimicrob Agents Chemother. 1990 Apr;34(4):676-9.

18.

Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.

Herrington DA, Clyde DF, Davis JR, Baqar S, Murphy JR, Cortese JF, Bank RS, Nardin E, DiJohn D, Nussenzweig RS, et al.

Bull World Health Organ. 1990;68 Suppl:33-7.

19.

Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer.

Nardin EH, Herrington DA, Davis J, Levine M, Stuber D, Takacs B, Caspers P, Barr P, Altszuler R, Clavijo P, et al.

Science. 1989 Dec 22;246(4937):1603-6.

PMID:
2480642
20.

Effect of priming with carrier on response to conjugate vaccine.

Di John D, Wasserman SS, Torres JR, Cortesia MJ, Murillo J, Losonsky GA, Herrington DA, Stürcher D, Levine MM.

Lancet. 1989 Dec 16;2(8677):1415-8.

PMID:
2480499
21.

Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3.

Davis JR, Murphy JR, Baqar S, Clyde DF, Herrington DA, Levine MM.

Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):748-50.

PMID:
2694506
23.

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, Levine MM.

J Exp Med. 1988 Oct 1;168(4):1487-92.

24.

A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines.

Herrington DA, Clyde DF, Murphy JR, Baqar S, Levine MM, do Rosario V, Hollingdale MR.

Trop Geogr Med. 1988 Apr;40(2):124-7.

PMID:
3043855
25.

Experimental human infections with Giardia lamblia.

Nash TE, Herrington DA, Losonsky GA, Levine MM.

J Infect Dis. 1987 Dec;156(6):974-84.

PMID:
3680997
26.

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.

Herrington DA, Clyde DF, Losonsky G, Cortesia M, Murphy JR, Davis J, Baqar S, Felix AM, Heimer EP, Gillessen D, et al.

Nature. 1987 Jul 16-22;328(6127):257-9.

PMID:
2439920
27.

Usefulness of an enzyme-linked immunosorbent assay for detection of Giardia antigen in feces.

Nash TE, Herrington DA, Levine MM.

J Clin Microbiol. 1987 Jul;25(7):1169-71.

28.

In vitro and in vivo pathogenicity of Plesiomonas shigelloides.

Herrington DA, Tzipori S, Robins-Browne RM, Tall BD, Levine MM.

Infect Immun. 1987 Apr;55(4):979-85.

29.

Life-threatening cat-scratch disease in an immunocompromised host.

Black JR, Herrington DA, Hadfield TL, Wear DJ, Margileth AM, Shigekawa B.

Arch Intern Med. 1986 Feb;146(2):394-6.

PMID:
3947199
30.

Haemophilus influenzae can use human transferrin as a sole source for required iron.

Herrington DA, Sparling PF.

Infect Immun. 1985 Apr;48(1):248-51.

Supplemental Content

Loading ...
Support Center